FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012272401> ?p ?o ?g. }

• W2012272401 endingPage "514" @default.
• W2012272401 startingPage "496" @default.
• W2012272401 abstract "Substantial morbidity, mortality, and costs are associated with progressive diabetic kidney disease (DKD). A goal of Healthy People 2020 is to reduce kidney disease attributable to diabetes mellitus and increase the proportion of patients who receive agents that interrupt the renin-angiotensin system (RAS), such as angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs). The mechanisms that contribute to progressive loss of kidney function in patients with diabetes are disrupted by inhibition of the RAS. ACEIs, ARBs and direct renin inhibitors (DRIs) all reduce the effect of angiotensin II, yet each works through a different mechanism and displays properties that may or may not be replicated by the others. As single agents, RAS inhibitors and blockers have been shown to slow the rate of progression of DKD and to reduce new cases of end-stage renal disease in various subsets of patients with diabetes and proteinuria (e.g., albuminuria). However, even with contemporary use of ACEIs, ARBs, and, more recently, DRIs, the burden of kidney disease remains high. Thus investigators sought to explore the utility of combining agents (e.g., dual RAS therapy) in various regimens for cardiovascular and kidney end points. Recent data from the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) and Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE) studies suggest that kidney-related outcomes (composite of dialysis initiation, doubling serum creatinine concentration, or death) were increased with ACEI plus ARB or DRI plus ARB combinations. Consequently, dual therapy should not be routinely prescribed in patients with diabetes until further data become available from other future studies. This review provides an introduction to DKD and a rationale for using RAS inhibition; discusses screening, detection, and monitoring of patients with DKD; and summarizes results from meta-analyses and critical reviews and from recent large randomized controlled studies published since the meta-analyses or reviews. Finally, we suggest a clinical approach for using RAS agents in patients with DKD." @default.
• W2012272401 created "2016-06-24" @default.
• W2012272401 creator A5006212343 @default.
• W2012272401 creator A5050833965 @default.
• W2012272401 creator A5059647784 @default.
• W2012272401 date "2013-04-09" @default.
• W2012272401 modified "2023-09-24" @default.
• W2012272401 title "To RAS or Not to RAS? The Evidence for and Cautions with Renin-Angiotensin System Inhibition in Patients with Diabetic Kidney Disease" @default.
• W2012272401 cites W1968233966 @default.
• W2012272401 cites W1973997307 @default.
• W2012272401 cites W1974162922 @default.
• W2012272401 cites W1983539151 @default.
• W2012272401 cites W1991652641 @default.
• W2012272401 cites W1997042641 @default.
• W2012272401 cites W2010611641 @default.
• W2012272401 cites W2010912810 @default.
• W2012272401 cites W2025906550 @default.
• W2012272401 cites W2032961459 @default.
• W2012272401 cites W2044773944 @default.
• W2012272401 cites W2046601853 @default.
• W2012272401 cites W2047335781 @default.
• W2012272401 cites W2047390341 @default.
• W2012272401 cites W2048695535 @default.
• W2012272401 cites W2054454858 @default.
• W2012272401 cites W2056976690 @default.
• W2012272401 cites W2064927835 @default.
• W2012272401 cites W2067535891 @default.
• W2012272401 cites W2073512707 @default.
• W2012272401 cites W2073742622 @default.
• W2012272401 cites W2074022279 @default.
• W2012272401 cites W2079169944 @default.
• W2012272401 cites W2081938413 @default.
• W2012272401 cites W2084030273 @default.
• W2012272401 cites W2093257785 @default.
• W2012272401 cites W2093410814 @default.
• W2012272401 cites W2093754226 @default.
• W2012272401 cites W2100409734 @default.
• W2012272401 cites W2100653164 @default.
• W2012272401 cites W2103318170 @default.
• W2012272401 cites W2106366762 @default.
• W2012272401 cites W2108266187 @default.
• W2012272401 cites W2111539598 @default.
• W2012272401 cites W2114614037 @default.
• W2012272401 cites W2117083889 @default.
• W2012272401 cites W2136145230 @default.
• W2012272401 cites W2137177722 @default.
• W2012272401 cites W2140317231 @default.
• W2012272401 cites W2143144750 @default.
• W2012272401 cites W2145632481 @default.
• W2012272401 cites W2146582345 @default.
• W2012272401 cites W2147201241 @default.
• W2012272401 cites W2147804563 @default.
• W2012272401 cites W2151888341 @default.
• W2012272401 cites W2155164384 @default.
• W2012272401 cites W2155965977 @default.
• W2012272401 cites W2161316366 @default.
• W2012272401 cites W2169506520 @default.
• W2012272401 cites W2170716254 @default.
• W2012272401 cites W2319998248 @default.
• W2012272401 cites W2337454357 @default.
• W2012272401 cites W2510708214 @default.
• W2012272401 cites W2904387867 @default.
• W2012272401 cites W4211154573 @default.
• W2012272401 cites W4212827053 @default.
• W2012272401 cites W4238687915 @default.
• W2012272401 cites W4246796472 @default.
• W2012272401 cites W4253337782 @default.
• W2012272401 cites W81008224 @default.
• W2012272401 doi "https://doi.org/10.1002/phar.1232" @default.
• W2012272401 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23576066" @default.
• W2012272401 hasPublicationYear "2013" @default.
• W2012272401 type Work @default.
• W2012272401 sameAs 2012272401 @default.
• W2012272401 citedByCount "25" @default.
• W2012272401 countsByYear W20122724012013 @default.
• W2012272401 countsByYear W20122724012014 @default.
• W2012272401 countsByYear W20122724012015 @default.
• W2012272401 countsByYear W20122724012016 @default.
• W2012272401 countsByYear W20122724012017 @default.
• W2012272401 countsByYear W20122724012018 @default.
• W2012272401 countsByYear W20122724012020 @default.
• W2012272401 countsByYear W20122724012021 @default.
• W2012272401 countsByYear W20122724012023 @default.
• W2012272401 crossrefType "journal-article" @default.
• W2012272401 hasAuthorship W2012272401A5006212343 @default.
• W2012272401 hasAuthorship W2012272401A5050833965 @default.
• W2012272401 hasAuthorship W2012272401A5059647784 @default.
• W2012272401 hasConcept C126322002 @default.
• W2012272401 hasConcept C126894567 @default.
• W2012272401 hasConcept C134018914 @default.
• W2012272401 hasConcept C159641895 @default.
• W2012272401 hasConcept C198710026 @default.
• W2012272401 hasConcept C27016395 @default.
• W2012272401 hasConcept C2776174234 @default.
• W2012272401 hasConcept C2777180221 @default.
• W2012272401 hasConcept C2777880890 @default.
• W2012272401 hasConcept C2778653478 @default.
• W2012272401 hasConcept C2779561371 @default.

• next